经典与新型超声征象对胎盘植入谱系疾病的评估
本研究为七家医疗中心回顾性队列,纳入孕中期前置胎盘并接受孕晚期经阴道超声的孕妇及所有胎盘植入谱系疾病(PAS)病例,由三名母胎医学医师回顾图像评估经典与新型超声征象。经典征象、新型征象及两者联合模型诊断PAS的AUC分别为0.81、0.84和0.88,联合模型优于单一模型(P=0.03);随着征象数目增加,PAS可能性增大。
要点
- 经典与新型超声征象联合模型诊断PAS的AUC为0.88,优于经典征象单独(0.81)或新型征象单独(0.84)。
- 出现0、1、2和≥3个经典超声征象时,PAS发生率分别为5%、24%、57%和94%。
- 联合模型与经典或新型征象单独相比差异有统计学意义(P=0.03)。
核心结论
- 经典超声征象对PAS的诊断价值得到确认,新型超声征象与经典征象联合使用可提高PAS的检出。
研究设计与样本
- 回顾性队列研究,纳入七家医疗中心孕中期前置胎盘并接受孕晚期经阴道超声的孕妇及所有PAS病例,共385例前置胎盘病例,其中55例PAS(28例胎盘粘连、11例胎盘植入、16例穿透性胎盘植入);由三名母胎医学医师回顾图像评估征象;PAS诊断基于胎盘剥离困难或胎盘病理检查。
关键影像表现/征象
- 经典征象包括胎盘陷窝、膀胱壁中断、子宫肌层变薄和胎盘下血流丰富。
- 新型征象包括小胎盘陷窝、胎盘-子宫肌层界面(PMI)不规则、PMI血管化、胎盘边缘不逐渐变细和胎盘向膀胱膨出。
诊断标准与关键数值
- 经典征象、新型征象及两者联合模型诊断PAS的AUC分别为0.81(95%CI 0.75-0.88)、0.84(95%CI 0.77-0.90)和0.88(95%CI 0.82-0.94)。
- 联合模型与经典征象或新型征象单独比较差异有统计学意义(P=0.03)。
- 出现0、1、2和≥3个经典超声征象时,PAS发生率分别为5%、24%、57%和94%。
临床应用与阅片要点
- 阅片时可同时评估经典与新型超声征象,联合应用有助于提高PAS检出。
- 征象数目越多,PAS可能性越大,报告中可描述征象数量。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: Improvement in the antenatal diagnosis of placenta accreta spectrum (PAS) would allow preparation for delivery in a referral center, leading to decreased maternal morbidity and mortality. Our objectives were to assess the performance of classic ultrasound signs and to determine the value of novel ultrasound signs in the detection of PAS.
METHODS: This was a retrospective cohort study of women with second-trimester placenta previa who underwent third-trimester transvaginal ultrasound and all women with PAS in seven medical centers. A retrospective image review for signs of PAS was conducted by three maternal-fetal medicine physicians. Classic signs of PAS were defined as placental lacunae, bladder-wall interruption, myometrial thinning and subplacental hypervascularity. Novel signs were defined as small placental lacunae, irregular placenta-myometrium interface (PMI), vascular PMI, non-tapered placental edge and placental bulge towards the bladder. PAS was diagnosed based on difficulty in removing the placenta or pathological examination of the placenta. Multivariate regression analysis was performed and receiver-operating-characteristics (ROC) curves were generated to assess the performance of combined novel signs, combined classic signs and a model combining classic and novel signs.
RESULTS: A total of 385 cases with placenta previa were included, of which 55 had PAS (28 had placenta accreta, 11 had placenta increta and 16 had placenta percreta). The areas under the ROC curves for classic markers, novel markers and a model combining classic and novel markers for the detection of PAS were 0.81 (95% CI, 0.75-0.88), 0.84 (95% CI, 0.77-0.90) and 0.88 (95% CI, 0.82-0.94), respectively. A model combining classic and novel signs performed better than did the classic or novel markers individually (P = 0.03). An increasing number of signs was associated with a greater likelihood of PAS. With the presence of 0, 1, 2 and ≥ 3 classic ultrasound signs, PAS was present in 5%, 24%, 57% and 94% of cases, respectively.
CONCLUSIONS: We have confirmed the value of classic ultrasound signs of PAS. The use of novel ultrasound signs in combination with classic signs improved the detection of PAS. These findings have clinical implications for the detection of PAS and may help guide the obstetric management of patients diagnosed with these placental disorders. © 2021 International Society of Ultrasound in Obstetrics and Gynecology.
引用
- Skupski DW, Duzyj CM, Scholl J, et al. Evaluation of classic and novel ultrasound signs of placenta accreta spectrum. Ultrasound Obstet Gynecol. 2022. PMID: 34725869. doi:10.1002/uog.24804
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。